Medicare

The world’s only long-term CGM is covered by Medicare and Medicare Advantage Plans.

Eligibility Criteria For Medicare Coverage

If you can answer yes to these questions, you could be eligible for the Eversense E3 CGM system under your Medicare and Medicare Advantage plan!

Do you have diabetes?

Are you treated with insulin 3 or more times per day and/or use an insulin pump?

Flexibility of Wear

Does your insulin treatment regimen require frequent adjustment based on BGM or CGM test results?

Have you visited your doctor within the past 6 months and at least once every 6 months?

GET STARTED NOW

Experience A Better Way To Manage Your Diabetes

DISCOVER EVERSENSE CGM SYSTEM

FAQ

Search our most commonly asked questions for quick answers.

VIEW FAQS
A man uses a computer to learn about the medicare requirements for continuous glucose monitoring.

Contact Us

Talk to a customer service team member today.

REACH OUT
Salesman smiling with headphones answers questions about the Eversense CGM app.

For those who qualify, Medicare users may pay as little as zero dollars out of pocket. Fill out this form to get started and we'll be in touch with next steps.

FILL OUT THE FORM

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

Get Started